{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:44:47Z","timestamp":1790095487144,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.neuropharm.2007.05.004","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T20:23:17Z","timestamp":1179606197000},"page":"189-193","source":"Crossref","is-referenced-by-count":86,"title":["Actions of N-arachidonyl-glycine in a rat neuropathic pain model"],"prefix":"10.1016","volume":"54","author":[{"given":"Leeza A.Q.","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.05.004_bib1","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1460-9568.2006.04684.x","article-title":"CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms","volume":"23","author":"Beltramo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","article-title":"The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain","volume":"133","author":"Bridges","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0163-7258(98)00069-2","article-title":"The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential","volume":"82","author":"Burstein","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib4","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.bmc.2007.03.026","article-title":"Potential anti-inflammatory actions of the elmiric (lipoamino) acids","volume":"15","author":"Burstein","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0006-2952(02)01301-1","article-title":"Regulation of anandamide tissue levels by N-arachidonylglycine","volume":"64","author":"Burstein","year":"2002","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2003.12.075","article-title":"A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase","volume":"314","author":"Cascio","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib8","first-page":"218","article-title":"Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities","volume":"265","author":"Compton","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2004.08.010","article-title":"Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity","volume":"112","author":"Cronin","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.103.062836","article-title":"3,2-Cyano-3-(trifluoromethyl)phenoxy phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid CB1\/CB2 receptor partial agonist with antihyperalgesic and antiallodynic effects","volume":"310","author":"De Vry","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral cannabinoid(1) receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib13","doi-asserted-by":"crossref","first-page":"42639","DOI":"10.1074\/jbc.M107351200","article-title":"Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2006.06.175","article-title":"Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18","volume":"347","author":"Kohno","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(03)00242-2","article-title":"Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats","volume":"105","author":"Lim","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","article-title":"CB2 cannabinoid receptor-mediated peripheral antinociception","volume":"93","author":"Malan","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib18","series-title":"Cannabinoids","first-page":"1","article-title":"Pharmacological actions of cannabinoids","volume":"vol. 168","author":"Pertwee","year":"2005"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0006-291X(02)00915-4","article-title":"Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2","volume":"296","author":"Prusakiewicz","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1460-9568.2005.04206.x","article-title":"Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats","volume":"22","author":"Sagar","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2004.01.020","article-title":"Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat","volume":"109","author":"Scott","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jn.1997.78.2.628","article-title":"Spinal strychnine alters response properties of nociceptive-specific neurons in rat medial thalamus","volume":"78","author":"Sherman","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm960752x","article-title":"Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor","volume":"40","author":"Sheskin","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib25","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(01)00798-1","article-title":"Cannabinoid CB1 receptor upregulation in a rat model of chronic neuropathic pain","volume":"415","author":"Siegling","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1189\/jlb.0205111","article-title":"Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders","volume":"78","author":"Sipe","year":"2005","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-4159.2006.04107.x","article-title":"N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a","volume":"99","author":"Wiles","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.05.004_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2005.06.009","article-title":"Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons","volume":"135","author":"Wotherspoon","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3959(89)90160-7","article-title":"Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists","volume":"37","author":"Yaksh","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.004_bib30","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T05:37:01Z","timestamp":1556429821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0028390807001311"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.05.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}